Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12 Month, Long-term Follow-up Study of Patients With Actinic Keratosis on the Head (Face or Scalp) Who Have Completed Day 57 in Studies PEP005-016 or PEP005-025 (REGION IIa and IIb)

NCT00953732 is registered in ClinicalTrials.gov with Peplin as lead sponsor.

NCT NCT00953732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00953732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12 Month, Long-term Follow-up Study of Patients With Actinic Keratosis on the Head (Face or Scalp) Who Have Completed Day 57 in Studies PEP005-016 or PEP005-025 (REGION IIa and IIb)
Lead sponsor
Peplin
Phase
Observational
Overall status
Completed
Start date
August 31, 2009
Completion date
October 31, 2010
Enrollment
117 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis